The right one depends on your biology, your cycle goals, and your lifestyle
In the COMBINE 3 trial in individuals with T2D inadequately controlled on daily basal insulin, IcoSema provided non-inferior reduction in HbA 1c from baseline to week 52 and superior body weight change and rate of combined clinically significant or severe hypoglycemia compared with basal-bolus insulin treatment that included once-daily insulin glargine U100 and insulin aspart given two to four times per day with main meals [15]
Individual weight loss varies, but patients taking Semaglutide injection for weight loss should see results in the first two weeks
SOLIQUA 100/33 (insulin glargine and lixisenatide injection), for subcutaneous use [prescribing information]
For some patients, maintenance involves: A lower dose than used during active weight loss Less frequent dosing Continued appetite support without ongoing weight loss The purpose of maintenance is stability, helping appetite feel manageable while healthy habits are fully established
If you know how many units you drew, read across to find the milligram dose